UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000062462
Receipt number R000071465
Scientific Title An Exploratory Study on Blood microRNAs Following Chocolate Ingestion
Date of disclosure of the study information 2026/08/04
Last modified on 2026/08/03 17:26:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An Exploratory Study on Blood microRNAs Following Chocolate Ingestion

Acronym

An Exploratory Study on Blood microRNAs Following Chocolate Ingestion

Scientific Title

An Exploratory Study on Blood microRNAs Following Chocolate Ingestion

Scientific Title:Acronym

An Exploratory Study on Blood microRNAs Following Chocolate Ingestion

Region

Japan


Condition

Condition

Healthy adult

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

This study aims to evaluate the relationship between serum microRNAs, body composition, and blood biomarkers in men and women aged 60 to 79 years following 16 weeks of continuous chocolate ingestion.
No new interventions will be conducted in this study; stored serum samples and clinical data previously collected in the UMIN000054576 study will be utilized.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes over time in normalized delta Ct values of serum microRNAs (up to approximately 10 types) before ingestion, and at 8 and 16 weeks after ingestion in the non-ingestion group and the chocolate ingestion group.
The primary analysis will evaluate the group-by-time interaction.

Key secondary outcomes

Association between changes in normalized delta Ct values of serum microRNAs and changes in body composition parameters, blood markers, etc.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

60 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

1. Subjects randomized to the non-ingestion group or the chocolate intervention group within the efficacy analysis population of UMIN000054576.
2. Subjects who agree to the secondary use of samples and data collected in UMIN000054576.

Key exclusion criteria

Subjects who decline the use of their samples or data for this study.

Target sample size

148


Research contact person

Name of lead principal investigator

1st name Naoyuki
Middle name
Last name HONMA

Organization

Hokkaido Information University

Division name

Department of Medical Management and Informatics

Zip code

069-8585

Address

59-2, Nishi-nopporo, Ebetsu, Hokkaido, 069-8585, Japan

TEL

011-385-4430

Email

hisc-acad.res@s.do-johodai.ac.jp


Public contact

Name of contact person

1st name Naoyuki
Middle name
Last name HONMA

Organization

Hokkaido Information University

Division name

Health Information Science Center

Zip code

069-0832

Address

45-7, Nishi-nopporo, Ebetsu, Hokkaido, 069-0832, Japan

TEL

011-385-4430

Homepage URL


Email

hisc-acad.res@s.do-johodai.ac.jp


Sponsor or person

Institute

Hokkaido Information University

Institute

Department

Personal name



Funding Source

Organization

Meiji Holdings Co., Ltd.
Meiji Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The ethics committee of Hokkaido Information University

Address

59-2, Nishi-nopporo, Ebetsu, Hokkaido, 069-8585, Japan

Tel

011-385-4411

Email

soumu@do-johodai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

北海道情報大学 健康情報科学研究センター(北海道)


Other administrative information

Date of disclosure of the study information

2026 Year 08 Month 04 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2026 Year 07 Month 27 Day

Date of IRB

2026 Year 07 Month 27 Day

Anticipated trial start date

2026 Year 09 Month 07 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

No new interventions will be conducted in this study; stored serum samples and clinical data previously collected in the UMIN000054576 study will be utilized.


Management information

Registered date

2026 Year 08 Month 04 Day

Last modified on

2026 Year 08 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071465